GALFO, VALENTINA
 Distribuzione geografica
Continente #
NA - Nord America 1.488
AS - Asia 555
EU - Europa 324
SA - Sud America 120
AF - Africa 18
OC - Oceania 2
Totale 2.507
Nazione #
US - Stati Uniti d'America 1.474
SG - Singapore 220
IT - Italia 146
CN - Cina 121
BR - Brasile 94
HK - Hong Kong 81
DE - Germania 49
VN - Vietnam 28
SE - Svezia 27
KR - Corea 23
GB - Regno Unito 20
FR - Francia 17
IN - India 15
JP - Giappone 13
BD - Bangladesh 12
FI - Finlandia 12
NL - Olanda 9
AR - Argentina 8
CA - Canada 8
TR - Turchia 8
CI - Costa d'Avorio 7
PL - Polonia 7
BG - Bulgaria 6
PE - Perù 6
RU - Federazione Russa 6
AT - Austria 5
JO - Giordania 5
PH - Filippine 5
SA - Arabia Saudita 5
CZ - Repubblica Ceca 4
IQ - Iraq 4
PK - Pakistan 4
SN - Senegal 4
VE - Venezuela 4
EC - Ecuador 3
EG - Egitto 3
CO - Colombia 2
ES - Italia 2
GR - Grecia 2
ID - Indonesia 2
LT - Lituania 2
MX - Messico 2
MY - Malesia 2
SK - Slovacchia (Repubblica Slovacca) 2
TW - Taiwan 2
UA - Ucraina 2
ZA - Sudafrica 2
AL - Albania 1
AU - Australia 1
AZ - Azerbaigian 1
CH - Svizzera 1
CL - Cile 1
CR - Costa Rica 1
CY - Cipro 1
DO - Repubblica Dominicana 1
HN - Honduras 1
HU - Ungheria 1
IE - Irlanda 1
IL - Israele 1
KE - Kenya 1
LV - Lettonia 1
MA - Marocco 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PA - Panama 1
RS - Serbia 1
SR - Suriname 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 2.507
Città #
Dallas 915
Singapore 136
Ashburn 111
Hong Kong 81
Santa Clara 69
Los Angeles 46
Shanghai 42
Florence 36
Chandler 31
Seoul 23
Beijing 19
Munich 19
Frankfurt am Main 17
New York 17
Boardman 14
Chicago 13
Buffalo 12
Pisa 12
Fairfield 11
Hefei 10
Tokyo 10
Hanoi 9
Ho Chi Minh City 9
Rome 9
São Paulo 9
Houston 8
Salt Lake City 8
Abidjan 7
Kent 7
London 7
Brooklyn 6
Cascina 6
Lima 6
Milan 6
Ogden 6
Porto Alegre 6
Redondo Beach 6
Sofia 6
Turku 6
Vicopisano 6
Wilmington 6
Amman 5
Denver 5
Lawrence 5
Nuremberg 5
Phoenix 5
Pontedera 5
Princeton 5
Seattle 5
Chennai 4
Dakar 4
Dhaka 4
Elk Grove Village 4
Fuzhou 4
Helsinki 4
Hyderabad 4
Istanbul 4
Lucca 4
Medford 4
Orem 4
San Francisco 4
Warsaw 4
Belo Horizonte 3
Bexley 3
Brasília 3
Brno 3
Cairo 3
Charlotte 3
Lauterbourg 3
Miami 3
Montreal 3
Osaka 3
Rio de Janeiro 3
Vienna 3
Wroclaw 3
Ann Arbor 2
Athens 2
Baghdad 2
Bari 2
Brescello 2
Calgary 2
Catania 2
Curitiba 2
Düsseldorf 2
Feira de Santana 2
Jeddah 2
Kuala Lumpur 2
La Plata 2
Lappeenranta 2
Livorno 2
Manchester 2
Manila 2
Medina 2
Messina 2
Prato 2
Reggio Emilia 2
Rimini 2
Rohr 2
San Diego 2
Sterling 2
Totale 1.964
Nome #
Predictors and outcomes of respiratory bacterial coinfections in patients with COVID-19 admitted to hospital: An observational prospective study 209
Clinical features and outcomes of infections caused by metallo-β-lactamases producing Enterobacterales: a 3-year prospective study from an endemic area 198
Pragmatic options for dose optimization of ceftazidime/avibactam with aztreonam in complex patients 198
Superinfections caused by carbapenem-resistant Enterobacterales in hospitalized patients with COVID-19: a multicentre observational study from Italy (CREVID Study) 188
Pharyngeal and cutaneous diphtheria: a tail of a refugee 165
What is the clinical significance of 'heteroresistance' in nonfermenting Gram-negative strains? 160
Patterns of Long COVID Symptoms: A Multi-Center Cross Sectional Study 159
Salvage therapy with sulbactam/durlobactam against cefiderocol-resistant Acinetobacter baumannii in a critically ill burn patient: clinical challenges and molecular characterization 153
Early Use of Remdesivir and Risk of Disease Progression in Hospitalized Patients With Mild to Moderate COVID-19 147
Therapeutic drug monitoring of antibiotics for methicillin-resistant Staphylococcus aureus infections: an updated narrative review for clinicians 142
Early Intra-Abdominal Bacterial Infections after Orthotopic Liver Transplantation: A Narrative Review for Clinicians 141
Bloodstream infections in patients with rectal colonization by Klebsiella pneumoniae producing different type of carbapenemases: a prospective, cohort study (CHIMERA study) 130
Efficacy and Safety of Nirmatrelvir/Ritonavir, Molnupiravir, and Remdesivir in a Real-World Cohort of Outpatients with COVID-19 at High Risk of Progression: The PISA Outpatient Clinic Experience 103
null 75
Risk factors and outcomes of fungal superinfections in patients with severe COVID-19: an observational study from Pisa academic hospital 65
Real-world experience with meropenem/vaborbactam for the treatment of infections caused by ESBL-producing Enterobacterales and carbapenem-resistant Klebsiella pneumoniae 50
Bacteremic nosocomial pneumonia caused by Gram-negative bacilli: results from the nationwide ALARICO study in Italy 49
Risk of SARS-CoV-2 infection and severe COVID-19 in hematological patients who received or not pre-exposure prophylaxis with tixagevimab/cilgavimab: a target trial emulation 46
Not all carbapenem-resistant Pseudomonas aeruginosa strains are alike: tailoring antibiotic therapy based on resistance mechanisms 37
Efficacy of ceftazidime-avibactam plus aztreonam in patients with bloodstream infections caused by MBL- producing Enterobacterales 37
AMRrounds: susceptibility to the new tetracycline-derivative eravacycline of New Delhi metallo-β-lactamase-producing Klebsiella pneumoniae complex 33
Severe respiratory failure in an immunocompetent host with invasive pulmonary aspergillosis and H1N1 influenza 29
Real-World Use, Effectiveness, and Safety of Intravenous Fosfomycin: The FORTRESS Study 18
How I manage patients with New Delhi metallo-beta-lactamase and OXA-48-producing Enterobacterales infections: a practical approach 17
Efficacy of Ceftazidime-avibactam Plus Aztreonam in Patients With Bloodstream Infections Caused by Metallo-β-lactamase-Producing Enterobacterales 11
Systematic Review and Meta-Analysis of Effects of Transfusion on Hemodynamic and Oxygenation Variables 3
Totale 2.563
Categoria #
all - tutte 6.247
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.247


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202125 0 0 0 0 0 2 13 0 6 1 0 3
2021/202252 2 2 0 0 4 5 3 5 5 2 9 15
2022/2023138 10 13 8 8 15 12 7 12 29 1 15 8
2023/2024125 9 4 12 5 15 12 10 6 2 5 27 18
2024/2025749 15 17 11 44 50 95 50 35 60 56 129 187
2025/20261.474 89 75 605 478 143 84 0 0 0 0 0 0
Totale 2.563